| Discipline | Oncology |
|---|---|
| Language | English |
| Edited by | George J. Delinasios |
| Publication details | |
| History | 1981–present |
| Publisher | International Institute of Anticancer Research (Greece) |
| Frequency | Monthly |
| Impact factor | 2.480 (2020) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Anticancer Res. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| ISSN | 0250-7005 (print) 1791-7530 (web) |
| OCLC no. | 07636918 |
| Links | |
Anticancer Research is an independent international peer-reviewed medical journal published by the International Institute of Anticancer Research, addressing experimental and clinical topics in oncology. Issues are released monthly print and online (by Highwire Press), and an annual Index is also published. Anticancer Research was established in 1981 by John G. Delinassios.
According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%.
According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
Abstracting and indexing
Articles in Anticancer Research are abstracted and/or indexed by:
- BIOBASE
- Biological Abstracts
- CAM abstracts
- Cambridge Scientific Abstracts
- Current Contents (Life Sciences)
- EMBASE
- EMBiology
- GEOBASE
- Pubmed/Medline
- Science Citation Index
- Scopus
- Web of Science
External links
  | This article about an oncology journal is a stub. You can help Misplaced Pages by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |